GLEMPA M 12.5/1000MG TAB

GLEMPA M is a combination tablet containing empagliflozin 12.5mg and metformin HCl 1000mg. It is used to manage type 2 diabetes mellitus by improving blood sugar control through dual mechanisms—empagliflozin works by increasing glucose excretion through urine, while metformin reduces hepatic glucose production and improves insulin sensitivity. This fixed-dose combination helps reduce the risk of cardiovascular events and is suitable for patients requiring enhanced glycemic control. Take as directed by your healthcare provider.